StonvexLoading…
StonvexStonvexStonvexCore line items from IHRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $884.12M | $3.86B | $2.74B | $1.74B |
Operating Income | $1.49M | $-20.64M | $-106.34M | $9.94M |
Net Income | $-95.22M | $-472.87M | $-430.97M | $-364.70M |
EPS (Diluted) | $-0.61 | $-3.06 | $-2.80 | $-2.38 |
Total Assets | $4.89B | $5.13B | $5.09B | $5.38B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $135.05M | $270.92M | $192.24M | $235.93M |
Free Cash Flow OCF − CapEx | $-114.45M | $10.91M | $-126.67M | $-93.85M |
Shares Outstanding | 155.79M | 154.29M | 5.04M | 153.38M |